Quality of Life
Conditions
Brief summary
The primary objective of this study is to understand if the test product (HUM supplement) improve symptoms experienced.
Detailed description
This will be a 2-arm randomized, double-blinded, placebo-controlled study.
Interventions
HUM supplement - 1 capsule per day
Placebo supplement - 1 capsule per day
Sponsors
Study design
Intervention model description
This will be a 2-arm randomized, double-blinded, placebo-controlled study
Eligibility
Inclusion criteria
* Female * Willing to maintain the current dietary pattern, activity level, and stable body weight for the duration of the study * Must be in good health (don't report any medical conditions asked in the screening questionnaire) * Willing and able to provide written informed consent
Exclusion criteria
* Allergies to any test product ingredients * Any other severe chronic disease * Pregnant, want to become pregnant for the duration of the study, or who are breastfeeding * Participating in an investigational health product research study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life improvements [Time Frame: Baseline to 8 weeks) | 8 week | Survey-based assessment (0-5 scale) with higher scores representing an improved outcome |
Countries
United States